219 related articles for article (PubMed ID: 36598981)
1. Structural basis for HIV-1 antagonism of host APOBEC3G via Cullin E3 ligase.
Ito F; Alvarez-Cabrera AL; Liu S; Yang H; Shiriaeva A; Zhou ZH; Chen XS
Sci Adv; 2023 Jan; 9(1):eade3168. PubMed ID: 36598981
[TBL] [Abstract][Full Text] [Related]
2. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
[TBL] [Abstract][Full Text] [Related]
3. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain.
Iwatani Y; Chan DS; Liu L; Yoshii H; Shibata J; Yamamoto N; Levin JG; Gronenborn AM; Sugiura W
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19539-44. PubMed ID: 19887642
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
Liu B; Sarkis PT; Luo K; Yu Y; Yu XF
J Virol; 2005 Aug; 79(15):9579-87. PubMed ID: 16014920
[TBL] [Abstract][Full Text] [Related]
6. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.
Han X; Liang W; Hua D; Zhou X; Du J; Evans SL; Gao Q; Wang H; Viqueira R; Wei W; Zhang W; Yu XF
J Virol; 2014 Mar; 88(6):3320-8. PubMed ID: 24390335
[TBL] [Abstract][Full Text] [Related]
7. MDM2 is a novel E3 ligase for HIV-1 Vif.
Izumi T; Takaori-Kondo A; Shirakawa K; Higashitsuji H; Itoh K; Io K; Matsui M; Iwai K; Kondoh H; Sato T; Tomonaga M; Ikeda S; Akari H; Koyanagi Y; Fujita J; Uchiyama T
Retrovirology; 2009 Jan; 6():1. PubMed ID: 19128510
[TBL] [Abstract][Full Text] [Related]
8. Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.
Chen C; Ma X; Hu Q; Li X; Huang F; Zhang J; Pan T; Xia J; Liu C; Zhang H
Retrovirology; 2017 Dec; 14(1):56. PubMed ID: 29258557
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta.
Miyagi E; Welbourn S; Sukegawa S; Fabryova H; Kao S; Strebel K
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941780
[TBL] [Abstract][Full Text] [Related]
10. ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.
Hüttenhain R; Xu J; Burton LA; Gordon DE; Hultquist JF; Johnson JR; Satkamp L; Hiatt J; Rhee DY; Baek K; Crosby DC; Frankel AD; Marson A; Harper JW; Alpi AF; Schulman BA; Gross JD; Krogan NJ
Cell Host Microbe; 2019 Jul; 26(1):86-99.e7. PubMed ID: 31253590
[TBL] [Abstract][Full Text] [Related]
11. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
Zhang W; Du J; Evans SL; Yu Y; Yu XF
Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated.
Dang Y; Siew LM; Zheng YH
J Biol Chem; 2008 May; 283(19):13124-31. PubMed ID: 18326044
[TBL] [Abstract][Full Text] [Related]
13. Aromatic disulfides as potential inhibitors against interaction between deaminase APOBEC3G and HIV infectivity factor.
Yan X; Chen C; Wang C; Lan W; Wang J; Cao C
Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(5):725-735. PubMed ID: 35920198
[TBL] [Abstract][Full Text] [Related]
14. The structural basis for HIV-1 Vif antagonism of human APOBEC3G.
Li YL; Langley CA; Azumaya CM; Echeverria I; Chesarino NM; Emerman M; Cheng Y; Gross JD
Nature; 2023 Mar; 615(7953):728-733. PubMed ID: 36754086
[TBL] [Abstract][Full Text] [Related]
15. Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association.
Fukuda H; Li S; Sardo L; Smith JL; Yamashita K; Sarca AD; Shirakawa K; Standley DM; Takaori-Kondo A; Izumi T
Front Cell Infect Microbiol; 2019; 9():129. PubMed ID: 31165049
[TBL] [Abstract][Full Text] [Related]
16. The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.
Donahue JP; Vetter ML; Mukhtar NA; D'Aquila RT
Virology; 2008 Jul; 377(1):49-53. PubMed ID: 18499212
[TBL] [Abstract][Full Text] [Related]
17. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.
Zhang W; Wang H; Li Z; Liu X; Liu G; Harris RS; Yu XF
J Virol; 2014 Nov; 88(21):12528-40. PubMed ID: 25142583
[TBL] [Abstract][Full Text] [Related]
18. Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
Ao Z; Yu Z; Wang L; Zheng Y; Yao X
PLoS One; 2008 Apr; 3(4):e1995. PubMed ID: 18414671
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.
Zuo T; Liu D; Lv W; Wang X; Wang J; Lv M; Huang W; Wu J; Zhang H; Jin H; Zhang L; Kong W; Yu X
J Virol; 2012 May; 86(10):5497-507. PubMed ID: 22379088
[TBL] [Abstract][Full Text] [Related]
20. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
